•
Sep 30, 2024

Pliant Therapeutics Q3 2024 Earnings Report

Total Revenue
$0
0
EPS
-$0.95
Previous year: -$0.7
+35.7%
Gross Profit
-$532K
Previous year: -$1.05M
-49.1%
Cash and Equivalents
$405M
Previous year: $524M
-22.7%
Free Cash Flow
-$33.2M
Previous year: -$36.3M
-8.7%
Total Assets
$446M
Previous year: $540M
-17.5%

Pliant Therapeutics

Pliant Therapeutics